Eagle Pharmaceuticals
EGRX
$4.57
Share price
3.63%
Change (1 day)
-84.33%
Change (1 year)
Categories
Number of shares outstanding for Eagle Pharmaceuticals (EGRX)
Number of shares outstanding as of May 2024 : 13,090,852
According to Eagle Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 13,090,852. At the end of 2023 the company had 13,090,852 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Eagle Pharmaceuticals from 2012 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 13.09 M | 0.58% |
| 2022 | 13.01 M | 0.93% |
| 2021 | 12.89 M | -4.69% |
| 2020 | 13.53 M | -0.84% |
| 2019 | 13.64 M | -5.02% |
| 2018 | 14.36 M | -3.52% |
| 2017 | 14.89 M | -2.63% |
| 2016 | 15.29 M | -1.95% |
| 2015 | 15.59 M | 11.16% |
| 2014 | 14.03 M | 0.82% |
| 2013 | 13.91 M | 31.7% |
| 2012 | 10.56 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,408,200,000 | 18,296.05% | 🇺🇸 USA |
 Novartis NVS | 2,044,000,000 | 15,513.96% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 949,379,000 | 7,152.23% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 3,986.82% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 15,353.54% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,034,500,000 | 15,441.39% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 8,463.23% | 🇮🇱 Israel |